Oatly Reports Fourth Quarter and Full Year 2022 Financial Results
Oatly Group AB (OTLY) reported fourth-quarter 2022 revenue of $195.1 million, a 4.9% increase year-over-year, with a net loss of $125.2 million compared to $79.8 million in Q4 2021. Total revenue for 2022 reached $722.2 million, up 12.3% from the previous year. The company also secured $425 million in financing commitments to fuel growth. Oatly anticipates 23% to 28% revenue growth in 2023 and aims for improved gross margins, expecting to reach the high-20s by Q4 2023. Despite the challenges, Oatly is focused on profitability and plans to achieve positive adjusted EBITDA in fiscal 2024, underpinned by significant supply chain improvements.
- Revenue increased by 4.9% year-over-year in Q4 2022.
- Total revenue for 2022 was $722.2 million, a 12.3% increase.
- Secured $425 million in financing commitments for growth.
- Expecting 23% to 28% revenue growth for 2023.
- Aiming for improved gross margin to reach high-20%s by Q4 2023.
- Net loss increased to $125.2 million in Q4 2022 from $79.8 million in Q4 2021.
- EBITDA loss of $111.2 million in Q4 2022, higher than $81.8 million in the previous year.
Fiscal Year 2023 Outlook Calls for Accelerated Growth and Improved Margins
Company Receives Financing Commitments of
MALMÖ, Sweden, March 15, 2023 (GLOBE NEWSWIRE) -- Oatly Group AB (Nasdaq: OTLY) (“Oatly” or the “Company”), the world’s original and largest oat drink company, today announced financial results for the fourth quarter and twelve months ended December 31, 2022.
Toni Petersson, Oatly’s CEO, commented, “I am proud of what the Oatly team accomplished in 2022. We took bold actions to strengthen our management team, transition our supply chain to a more asset-light model, and simplify our cost structure. We finished the year with a solid fourth quarter, and we have continued that momentum into 2023 by closing the Ya YA Foods transaction and raising
Petersson continued, “Our supply chain is back on firmer footing, we have clear line of sight to reaching profitability, and we have the liquidity needed to fully fund our growth investments and reach financial self-sufficiency. Therefore, we believe we are well-positioned to start playing offense in 2023. Our teams will be focused on fully capturing the underlying global demand for our products while continuously improving our supply chain. We expect this focus to enable us to move along our path to profitability, set up fiscal 2024 for positive adjusted EBITDA, and drive sustainable, long-term shareholder value creation."
Financing Update
As announced in a separate press release today, the Company entered into certain transactions for
Three Months Ended December 31, | $ Change | % Change | |||||||||||||||||||||||||
Revenue (in thousands of U.S. dollars) | 2022 | 2021 | As reported | Foreign exchange impact | In constant currency | As reported | In constant currency | Volume | Constant currency price/mix | ||||||||||||||||||
EMEA | 89,974 | 88,881 | 89,974 | 12,615 | 102,589 | 1.2 | % | 15.4 | % | 11.5 | % | 3.9 | % | ||||||||||||||
Americas | 64,386 | 55,487 | 64,386 | — | 64,386 | 16.0 | % | 16.0 | % | -0.2 | % | 16.2 | % | ||||||||||||||
Asia | 40,708 | 41,557 | 40,708 | 4,019 | 44,727 | -2.0 | % | 7.6 | % | 22.1 | % | -14.5 | % | ||||||||||||||
Total revenue | 195,068 | 185,925 | 195,068 | 16,634 | 211,702 | 4.9 | % | 13.9 | % | 10.0 | % | 3.9 | % | ||||||||||||||
Twelve Months Ended December 31, | $ Change | % Change | |||||||||||||||||||||||||
Revenue (in thousands of U.S. dollars) | 2022 | 2021 | As reported | Foreign exchange impact | In constant currency | As reported | In constant currency | Volume | Constant currency price/mix | ||||||||||||||||||
EMEA | 345,509 | 336,452 | 345,509 | 43,166 | 388,675 | 2.7 | % | 15.5 | % | 13.7 | % | 1.8 | % | ||||||||||||||
Americas | 223,880 | 179,830 | 223,880 | — | 223,880 | 24.5 | % | 24.5 | % | 23.2 | % | 1.3 | % | ||||||||||||||
Asia | 152,849 | 126,908 | 152,849 | 6,811 | 159,660 | 20.4 | % | 25.8 | % | 31.9 | % | -6.1 | % | ||||||||||||||
Total revenue | 722,238 | 643,190 | 722,238 | 49,977 | 772,215 | 12.3 | % | 20.1 | % | 19.1 | % | 1.0 | % | ||||||||||||||
Recent Highlights
- Revenue of
$195.1 million , a4.9% increase compared to the prior year period, constant currency revenue increased13.9% . - Gross margin in the quarter was
15.9% , which is flat compared to the prior year period and an increase of over 13 percentage points compared to the third quarter. - Net loss attributable to shareholders of the parent was
$125.2 million compared to net loss of$79.8 million in the prior year period. - EBITDA loss of
$111.2 million ; adjusted EBITDA loss of$60.5 million , which is an improvement of$5.1 million compared to the prior year period and an improvement of$22.2 million compared to the third quarter. - Subsequent to quarter-end, the Company completed the transaction to partner with Ya YA Foods on a strategic hybrid manufacturing alliance in North America (the “YYF transaction”).
- Subsequent to quarter-end, the Company received commitments for
$425 million of capital and has agreed on terms and conditions with lenders to amend its revolving credit facility. The Company expects the new capital to fully fund its growth investments until the company becomes financially self-sufficient. - The Company provided its 2023 outlook, which calls for
23% to28% constant currency revenue growth, gross margin to improve sequentially through the year and reach the high-20% s by the fourth quarter. The Company believes this progress will enable full year fiscal 2024 to deliver positive adjusted EBITDA.
Fourth Quarter 2022 Results
Revenue increased
The Company has continued to experience revenue growth in the retail channel. In the fourth quarter of 2022 and 2021, the retail channel accounted for
Gross profit was
- Supply chain improvements in Americas and EMEA, including improved absorption and productivity as well as fewer one-off expenses, of 660 basis points,
- COVID-19 restrictions easing in Asia that resulted in better utilization of the Asia facilities and fewer one-off expenses of 430 basis points,
- Pricing actions of 140 basis points,
- Deflationary costs of 60 basis points, mainly driven by lower energy costs,
- Other items, net, of approximately 30 basis points.
Research and development expenses in the fourth quarter of 2022 increased
Selling, general and administrative expenses in the fourth quarter of 2022 decreased
Other operating (expenses) and income, net for the fourth quarter of 2022 decreased to an expense of
Net loss attributable to shareholders of the parent was
EBITDA loss for the fourth quarter of 2022 was
Adjusted EBITDA loss for the fourth quarter of 2022 was
EBITDA, Adjusted EBITDA (Loss), and revenue at constant currency are non-IFRS financial measures defined under “Non-IFRS financial measures.” Please see above revenue at constant currency table and “Reconciliation of IFRS to Non-IFRS Results” at the end of this press release.
The following tables set forth revenue, Adjusted EBITDA, EBITDA and loss before income tax for the Company’s three reportable segments for the periods presented.
Revenue, Adjusted EBITDA and EBITDA
Three Months Ended December 31, 2022 (in thousands of U.S. dollars) | EMEA | Americas | Asia | Corporate* | Eliminations** | Total | ||||||||||||||||||
Revenue | ||||||||||||||||||||||||
Revenue from external customers | 89,974 | 64,386 | 40,708 | — | — | 195,068 | ||||||||||||||||||
Intersegment revenue | 4,165 | — | 2,187 | — | (6,352 | ) | — | |||||||||||||||||
Total segment revenue | 94,139 | 64,386 | 42,895 | — | (6,352 | ) | 195,068 | |||||||||||||||||
Adjusted EBITDA | 1,735 | (4,661 | ) | (21,004 | ) | (36,534 | ) | — | (60,464 | ) | ||||||||||||||
Share-based compensation expense | (1,121 | ) | (763 | ) | (1,327 | ) | (4,530 | ) | — | (7,741 | ) | |||||||||||||
Restructuring costs(1) | (918 | ) | (797 | ) | (309 | ) | (1,386 | ) | — | (3,410 | ) | |||||||||||||
Asset impairment charge and other costs related to assets held for sale(2) | — | (39,581 | ) | — | — | — | (39,581 | ) | ||||||||||||||||
EBITDA | (304 | ) | (45,802 | ) | (22,640 | ) | (42,450 | ) | — | (111,196 | ) | |||||||||||||
Finance income and (expenses), net | — | — | — | — | — | 3,098 | ||||||||||||||||||
Depreciation and amortization | — | — | — | — | — | (13,835 | ) | |||||||||||||||||
Loss before tax | — | — | — | — | — | (121,933 | ) | |||||||||||||||||
Three Months Ended December 31, 2021 (in thousands of U.S. dollars) | EMEA | Americas | Asia | Corporate* | Eliminations** | Total | ||||||||||||||||||
Revenue | ||||||||||||||||||||||||
Revenue from external customers | 88,881 | 55,487 | 41,557 | — | — | 185,925 | ||||||||||||||||||
Intersegment revenue | 28,401 | 311 | — | — | (28,712 | ) | — | |||||||||||||||||
Total segment revenue | 117,282 | 55,798 | 41,557 | — | (28,712 | ) | 185,925 | |||||||||||||||||
Adjusted EBITDA | (2,779 | ) | (8,708 | ) | (14,948 | ) | (39,174 | ) | — | (65,609 | ) | |||||||||||||
Share-based compensation expense | (1,547 | ) | (1,215 | ) | (1,725 | ) | (5,111 | ) | — | (9,598 | ) | |||||||||||||
Product recall expenses(3) | (1,654 | ) | — | — | — | — | (1,654 | ) | ||||||||||||||||
Asset impairment charge(4) | (4,970 | ) | — | — | — | — | (4,970 | ) | ||||||||||||||||
EBITDA | (10,950 | ) | (9,923 | ) | (16,673 | ) | (44,285 | ) | — | (81,831 | ) | |||||||||||||
Finance income and (expenses), net | — | — | — | — | — | 7,480 | ||||||||||||||||||
Depreciation and amortization | — | — | — | — | — | (10,836 | ) | |||||||||||||||||
Loss before tax | — | — | — | — | — | (85,187 | ) | |||||||||||||||||
Twelve Months Ended December 31, 2022 (in thousands of U.S. dollars) | EMEA | Americas | Asia | Corporate* | Eliminations** | Total | ||||||||||||||||||
Revenue | ||||||||||||||||||||||||
Revenue from external customers | 345,509 | 223,880 | 152,849 | — | — | 722,238 | ||||||||||||||||||
Intersegment revenue | 34,940 | 820 | 3,659 | — | (39,419 | ) | — | |||||||||||||||||
Total segment revenue | 380,449 | 224,700 | 156,508 | — | (39,419 | ) | 722,238 | |||||||||||||||||
Adjusted EBITDA | (10,298 | ) | (62,837 | ) | (75,183 | ) | (119,605 | ) | — | (267,923 | ) | |||||||||||||
Share-based compensation expense | (4,314 | ) | (4,485 | ) | (6,973 | ) | (19,694 | ) | — | (35,466 | ) | |||||||||||||
Restructuring costs(1) | (918 | ) | (797 | ) | (309 | ) | (2,391 | ) | — | (4,415 | ) | |||||||||||||
Asset impairment charge and other costs related to assets held for sale(2) | — | (39,581 | ) | — | — | — | (39,581 | ) | ||||||||||||||||
EBITDA | (15,530 | ) | (107,700 | ) | (82,465 | ) | (141,690 | ) | — | (347,385 | ) | |||||||||||||
Finance income and (expenses), net | — | — | — | — | — | (1,409 | ) | |||||||||||||||||
Depreciation and amortization | — | — | — | — | — | (48,600 | ) | |||||||||||||||||
Loss before tax | — | — | — | — | — | (397,394 | ) | |||||||||||||||||
Twelve Months Ended December 31, 2021 (in thousands of U.S. dollars) | EMEA | Americas | Asia | Corporate* | Eliminations** | Total | ||||||||||||||||||
Revenue | ||||||||||||||||||||||||
Revenue from external customers | 336,452 | 179,830 | 126,908 | — | — | 643,190 | ||||||||||||||||||
Intersegment revenue | 89,460 | 908 | — | — | (90,368 | ) | — | |||||||||||||||||
Total segment revenue | 425,912 | 180,738 | 126,908 | — | (90,368 | ) | 643,190 | |||||||||||||||||
Adjusted EBITDA | 21,959 | (44,560 | ) | (16,480 | ) | (107,896 | ) | — | (146,977 | ) | ||||||||||||||
Share-based compensation expense | (3,780 | ) | (2,963 | ) | (4,192 | ) | (12,697 | ) | — | (23,632 | ) | |||||||||||||
Product recall(3) | (1,654 | ) | — | — | — | — | (1,654 | ) | ||||||||||||||||
Asset impairment charge(4) | (4,970 | ) | — | — | — | — | (4,970 | ) | ||||||||||||||||
IPO preparation and transaction costs | — | — | — | (9,288 | ) | — | (9,288 | ) | ||||||||||||||||
EBITDA | 11,555 | (47,523 | ) | (20,672 | ) | (129,881 | ) | — | (186,521 | ) | ||||||||||||||
Finance income and (expenses), net | — | — | — | — | — | (1,305 | ) | |||||||||||||||||
Depreciation and amortization | — | — | — | — | — | (27,222 | ) | |||||||||||||||||
Loss before tax | — | — | — | — | — | (215,048 | ) |
_________________
* Corporate consists of general overhead costs not allocated to the segments.
** Eliminations in 2022 refer to intersegment revenue for sales of products from EMEA to Americas and Asia, from Americas to Asia and from Asia to EMEA. Eliminations in 2021 and 2020 refer to intersegment revenue for sales of products from EMEA to Americas and Asia, and from Americas to Asia.
(1) Relates to accrued severance payments as the Company reviews its organizational structure to adjust the fixed cost base globally.
(2) The 2022 asset impairment charge relates to the YYF transaction. See the Company’s Form 6-K filed on January 3, 2023 and March 2, 2023 for details on the YYF transaction.
(3) Relates to the recall of products in Sweden as communicated on November 17, 2021. See the Company’s Form 6-K filed on November 17, 2021.
(4) The 2021 asset impairment charge related to production equipment at our Landskrona production facility in Sweden for which we had no alternative use.
EMEA
EMEA revenue increased
EMEA EBITDA loss decreased
Americas
Americas revenue increased
Americas EBITDA loss increased
Asia
Asia revenue continued to be impacted by COVID-19 variants in China in the fourth quarter 2022. Despite this, Asia revenue only decreased
Asia EBITDA loss increased
Corporate Expense
Oatly’s corporate expense, which consists of general overhead costs not allocated to the segments, in the fourth quarter of 2022 was
Balance Sheet and Cash Flow
As of December 31, 2022, the Company had cash and cash equivalents of
Outlook
The Company’s outlook assumes reasonable containment of COVID-19 related infection rates globally, including no further major lockdowns in Asia, and does not reflect any additional deterioration in the European macro environment, or any significant changes in the geopolitical impact of the current war in Ukraine. Based on the Company’s assessment of the current operating environment, including inflation, rising interest rates, and the impact on consumer behavior, the Company expects the following for the full year ending December 31, 2023:
- Revenue growth of
23% to28% on a constant currency basis compared to full year 2022. The Company currently expects foreign currency to be a headwind of approximately 250 basis points for the year, - Gross margin to improve sequentially quarter-over-quarter in fiscal 2023, reaching the high
-20% s in the fourth quarter, - Capital expenditures between
$180 million and$200 million .
The Company believes this progress will enable full year fiscal 2024 to deliver positive adjusted EBITDA.
Longer-term, the Company expects:
- To generate gross profit margin in the range of
35% to40% , - Adjusted EBITDA margin in the mid- to high-teens.
The Company cannot provide a reconciliation of Adjusted EBITDA or Adjusted EBITDA margin guidance to the corresponding IFRS metric without unreasonable efforts due to difficulty in predicting certain items excluded from this non-IFRS measure. The items necessary to reconcile are not within Oatly’s control, may vary greatly between periods and could significantly impact future financial results.
Conference Call, Webcast and Supplemental Presentation Details
Oatly will host a conference call and webcast at 8:30 a.m. ET today to discuss these results. The conference call, simultaneous, live webcast and supplemental presentation can be accessed on Oatly’s Investors website under “Events.” The webcast will be archived for 30 days.
About Oatly
We are the world’s original and largest oat drink company. For over 25 years, we have exclusively focused on developing expertise around oats: a global power crop with inherent properties suited for sustainability and human health. Our commitment to oats has resulted in core technical advancements that enabled us to unlock the breadth of the dairy portfolio, including alternatives to milks, ice cream, yogurt, cooking creams, and spreads. Headquartered in Malmö, Sweden, the Oatly brand is available in more than 20 countries globally.
For more information, please visit our website.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any express or implied statements contained in this press release that are not statements of historical fact may be deemed to be forward-looking statements, including, without limitation, statements regarding our financial outlook for 2023 and long-term growth strategy, and anticipated cost savings from our restructuring plans, as well as statements that include the words “expect,” “intend,” “plan,” “believe,” “project,” “forecast,” “estimate,” “may,” “should,” “anticipate,” “will,” “aim,” “potential,” “continue,” “is/are likely to” and similar statements of a future or forward-looking nature. Forward-looking statements are neither promises nor guarantees, but involve known and unknown risks and uncertainties that could cause actual results to differ materially from those projected, including, without limitation: general economic conditions including high inflationary cost pressures, interest rates and supply chain constraints; our history of losses and inability to achieve or sustain profitability; our ability to manage our growth effectively; the impact of the COVID-19 pandemic, including the spread of variants of the virus, on our business and the international economy; reduced or limited availability of oats or other raw materials and ingredients that meet our quality standards; failure to obtain additional financing to achieve our goals or failure to obtain necessary capital when needed on acceptable terms, or at all; damage or disruption to our production facilities; harm to our brand and reputation as a result of real or perceived quality or food safety issues with our products; food safety and food-borne illness incidents or other safety concerns which may lead to lawsuits, product recalls or regulatory enforcement actions; our ability to successfully compete in our highly competitive markets; our ability to effectively manage our growth, realize the anticipated benefits of the reduction in force and retain our existing employees; changing consumer preferences due to disposable income, credit availability, debt levels and inflation, and our ability to adapt to new or changing preferences; foreign exchange rate fluctuations; the consolidation of customers or the loss of a significant customer; reduction in the sales of our oatmilk varieties; failure to meet our existing or new environmental metrics and other risks related to sustainability and corporate social responsibility; litigation, regulatory actions or other legal proceedings including environmental and securities class action lawsuits; changes to international trade policies, treaties and tariffs; global conflict and the ongoing war in Ukraine; changes in our tax rates or exposure to additional tax liabilities or assessments; failure to expand our manufacturing and production capacity as we grow our business; supply chain delays, including delays in the receipt of product at factories and ports, and an increase in transportation costs; the impact of rising commodity prices, transportation and labor costs on our cost of goods sold; failure by our logistics providers to deliver our products on time, or at all; our ability to successfully ramp up operations at any of our new facilities and operate them in accordance with our expectations; failure to develop and maintain our brand; our ability to introduce new products or successfully improve existing products; failure to retain our senior management or to attract, train and retain employees; cybersecurity incidents or other technology disruptions; failure to protect our intellectual property and other proprietary rights adequately; our ability to successfully remediate previously disclosed material weaknesses (which remained unremediated as of our most recent fiscal year end) or other future control deficiencies, in our internal control over financial reporting; our status as a foreign private issuer; risks related to the significant influence of our largest shareholder, Nativus Company Limited, entities affiliated with China Resources Verlinvest Health Investment Ltd. has over us, including significant influence over decisions that require the approval of shareholders; and the other important factors discussed under the caption “Risk Factors” in our Annual Report on Form 20-F for the year ended December 31, 2021 filed with the U.S. Securities and Exchange Commission (“SEC”) on April 6, 2022, in our Report on Form 6-K for the period ended September 30, 2022 filed with the SEC on November 14, 2022, and our other filings with the SEC as such factors may be updated from time to time. Any forward-looking statements contained in this press release speak only as of the date hereof and accordingly undue reliance should not be placed on such statements. Oatly disclaims any obligation or undertaking to update or revise any forward-looking statements contained in this press release, whether as a result of new information, future events or otherwise, other than to the extent required by applicable law.
Non-IFRS Financial Measures
EBITDA, Adjusted EBITDA, Adjusted EBITDA margin and constant currency revenue are financial measures that are not calculated in accordance with IFRS. We define Adjusted EBITDA as loss for the period attributable to shareholders of the parent adjusted to exclude, when applicable, income tax expense, finance expenses, finance income, depreciation and amortization expense, share-based compensation expense, restructuring costs, asset impairment charge and other costs related to assets held for sale, and IPO preparation and transaction costs.
Adjusted EBITDA should not be considered as an alternative to loss for the period or any other measure of financial performance calculated and presented in accordance with IFRS. There are a number of limitations related to the use of Adjusted EBITDA rather than loss for the period attributable to shareholders of the parent, which is the most directly comparable IFRS measure. Some of these limitations are:
- Adjusted EBITDA excludes depreciation and amortization expense and, although these are non-cash expenses, the assets being depreciated may have to be replaced in the future increasing our cash requirements;
- Adjusted EBITDA does not reflect interest expense, or the cash required to service our debt, which reduces cash available to us;
- Adjusted EBITDA does not reflect income tax payments that reduce cash available to us;
- Adjusted EBITDA does not reflect recurring share-based compensation expense and, therefore, does not include all of our compensation costs;
- Adjusted EBITDA does not reflect restructuring costs that reduce cash available to us in future periods;
- Adjusted EBITDA excludes asset impairment charge and other costs related to assets held for sale, although these are non-cash expenses, the assets being impaired may have to be replaced in the future increasing our cash requirements;
- Adjusted EBITDA does not reflect non-recurring expenses related to the IPO that reduce cash available to us; and
- Other companies, including companies in our industry, may calculate Adjusted EBITDA differently, which reduces its usefulness as a comparative measure.
Adjusted EBITDA should not be considered in isolation or as a substitute for financial information provided in accordance with IFRS. Below we have provided a reconciliation of Adjusted EBITDA to loss attributable to shareholders of the parent, the most directly comparable financial measure calculated and presented in accordance with IFRS, for the period presented.
This press release also includes references to constant currency revenue. The Company presents this measure because we use constant currency information to provide a framework in assessing how our business and geographic segments performed excluding the effects of foreign currency exchange rate fluctuations and believe this information is useful to investors to facilitate comparisons and better identify trends in our business. The constant currency measure is calculated by translating the current year reported revenue amounts into comparable amounts using the prior year reporting period’s average foreign exchange rates which have been provided by a third party. Above we have provided a reconciliation of revenue as reported to revenue on a constant currency basis for the periods presented.
Financial Statements
Consolidated statement of operations
(Unaudited) | Three months ended December 31, | Twelve months ended December 31, | ||||||||||||||||
(in thousands of U.S. dollars, except share and per share data) | 2022 | 2021 | 2022 | 2021 | ||||||||||||||
Revenue | 195,068 | 185,925 | 722,238 | 643,190 | ||||||||||||||
Cost of goods sold | (164,015 | ) | (156,330 | ) | (642,211 | ) | (488,177 | ) | ||||||||||
Gross profit | 31,053 | 29,595 | 80,027 | 155,013 | ||||||||||||||
Research and development expenses | (7,035 | ) | (5,675 | ) | (22,262 | ) | (16,771 | ) | ||||||||||
Selling, general and administrative expenses | (107,901 | ) | (118,900 | ) | (412,799 | ) | (353,929 | ) | ||||||||||
Other operating (expenses) and income, net | (41,148 | ) | 2,313 | (40,951 | ) | 1,944 | ||||||||||||
Operating loss | (125,031 | ) | (92,667 | ) | (395,985 | ) | (213,743 | ) | ||||||||||
Finance income and (expenses), net | 3,098 | 7,480 | (1,409 | ) | (1,305 | ) | ||||||||||||
Loss before tax | (121,933 | ) | (85,187 | ) | (397,394 | ) | (215,048 | ) | ||||||||||
Income tax (expense)/benefit | (3,236 | ) | 5,434 | 4,827 | 2,655 | |||||||||||||
Loss for the period attributable to shareholders of the parent | (125,169 | ) | (79,753 | ) | (392,567 | ) | (212,393 | ) | ||||||||||
Loss per share, attributable to shareholders of the parent: | ||||||||||||||||||
Basic and diluted | (0.21 | ) | (0.13 | ) | (0.66 | ) | (0.39 | ) | ||||||||||
Weighted average common shares outstanding: | ||||||||||||||||||
Basic and diluted | 592,234,975 | 591,777,001 | 592,031,935 | 549,080,310 | ||||||||||||||
Consolidated statement of financial position
(Unaudited) | December 31, 2022 | December 31, 2021 | ||||||
(in thousands of U.S. dollars) | ||||||||
ASSETS | ||||||||
Non-current assets | ||||||||
Intangible assets | 127,688 | 145,925 | ||||||
Property, plant and equipment | 492,952 | 509,648 | ||||||
Right-of-use assets | 108,598 | 158,448 | ||||||
Other non-current receivables | 7,848 | 5,534 | ||||||
Deferred tax assets | 5,860 | 2,293 | ||||||
Total non-current assets | 742,946 | 821,848 | ||||||
Current assets | ||||||||
Inventories | 114,475 | 95,661 | ||||||
Trade receivables | 100,955 | 105,519 | ||||||
Current tax assets | 243 | 435 | ||||||
Other current receivables | 17,818 | 32,229 | ||||||
Prepaid expenses | 23,413 | 27,711 | ||||||
Short-term investments | — | 249,937 | ||||||
Cash and cash equivalents | 82,644 | 295,572 | ||||||
339,548 | 807,064 | |||||||
Assets held for sale | 142,703 | — | ||||||
Total current assets | 482,251 | 807,064 | ||||||
TOTAL ASSETS | 1,225,197 | 1,628,912 | ||||||
EQUITY AND LIABILITIES | ||||||||
Equity | ||||||||
Share capital | 105 | 105 | ||||||
Other contributed capital | 1,628,045 | 1,628,103 | ||||||
Foreign currency translation reserve | (171,483 | ) | (74,486 | ) | ||||
Accumulated deficit | (665,524 | ) | (308,423 | ) | ||||
Total equity attributable to shareholders of the parent | 791,143 | 1,245,299 | ||||||
Liabilities | ||||||||
Non-current liabilities | ||||||||
Lease liabilities | 82,285 | 126,516 | ||||||
Liabilities to credit institutions | 2,668 | — | ||||||
Deferred tax liabilities | — | 2,677 | ||||||
Provisions | 7,194 | 11,033 | ||||||
Total non-current liabilities | 92,147 | 140,226 | ||||||
Current liabilities | ||||||||
Lease liabilities | 16,823 | 16,703 | ||||||
Liabilities to credit institutions | 49,922 | 5,987 | ||||||
Trade payables | 82,516 | 93,043 | ||||||
Current tax liabilities | 5,515 | 567 | ||||||
Other current liabilities | 11,823 | 9,614 | ||||||
Accrued expenses | 123,037 | 117,473 | ||||||
Provisions | 3,800 | — | ||||||
293,436 | 243,387 | |||||||
Liabilities directly associated with the assets held for sale | 48,471 | — | ||||||
Total current liabilities | 341,907 | 243,387 | ||||||
Total liabilities | 434,054 | 383,613 | ||||||
TOTAL EQUITY AND LIABILITIES | 1,225,197 | 1,628,912 | ||||||
Consolidated statement of cash flows
(Unaudited) | For the year ended December 31 | |||||||
(in thousands of U.S. dollars) | 2022 | 2021 | ||||||
Operating activities | ||||||||
Net loss | (392,567 | ) | (212,393 | ) | ||||
Adjustments to reconcile net loss to net cash flows | ||||||||
Depreciation of property, plant and equipment and right-of-use assets and amortization of intangible assets | 48,315 | 27,222 | ||||||
Impairment of property, plant and equipment and right-of-use assets | 285 | 4,970 | ||||||
Impairment related to assets held for sale | 38,293 | — | ||||||
Impairment loss/(gain) on trade receivables | 3,088 | (253 | ) | |||||
Write-down of inventories | 28,839 | 5,081 | ||||||
Share-based payments expense | 35,466 | 23,632 | ||||||
Movements in provisions | 3,800 | — | ||||||
Finance expenses and (income), net | 1,409 | 1,305 | ||||||
Income tax benefit | (4,827 | ) | (2,655 | ) | ||||
(Gain)/loss on disposal of property, plant and equipment and intangible assets | (932 | ) | 422 | |||||
Other | (226 | ) | (138 | ) | ||||
Interest received | 2,145 | 1,740 | ||||||
Interest paid | (12,875 | ) | (9,237 | ) | ||||
Income tax paid | (2,960 | ) | (2,734 | ) | ||||
Changes in working capital: | ||||||||
Increase in inventories | (55,018 | ) | (63,688 | ) | ||||
Decrease/(increase) in trade receivables, other current receivables, prepaid expenses | 6,991 | (79,278 | ) | |||||
Increase in trade payables, other current liabilities, accrued expenses | 31,828 | 92,172 | ||||||
Net cash flows used in operating activities | (268,946 | ) | (213,832 | ) | ||||
Investing activities | ||||||||
Purchase of intangible assets | (4,510 | ) | (7,838 | ) | ||||
Purchase of property, plant and equipment | (201,655 | ) | (273,760 | ) | ||||
Investments in financial assets | — | (1,162 | ) | |||||
Proceeds from financial instruments | — | 5,720 | ||||||
Purchase of short-term investments | — | (385,165 | ) | |||||
Proceeds from short-term investments | 240,959 | 117,877 | ||||||
Net cash flows from/(used in) investing activities | 34,794 | (544,328 | ) | |||||
Financing activities | ||||||||
Proceeds from issue of shares, net of transaction costs | — | 1,037,325 | ||||||
Repayment of shareholder loans | — | (10,941 | ) | |||||
Proceeds from liabilities to credit institutions | 47,850 | 118,005 | ||||||
Repayment of liabilities to credit institutions | (1,032 | ) | (212,913 | ) | ||||
Repayment of lease liabilities | (10,899 | ) | (9,282 | ) | ||||
Proceeds from exercise of warrants | — | 38,503 | ||||||
Payment of loan transaction costs | — | (4,900 | ) | |||||
Cash flows from financing activities | 35,919 | 955,797 | ||||||
Net (decrease)/increase in cash and cash equivalents | (198,233 | ) | 197,637 | |||||
Cash and cash equivalents at January 1 | 295,572 | 105,364 | ||||||
Exchange rate differences in cash and cash equivalents | (14,695 | ) | (7,429 | ) | ||||
Cash and cash equivalents at December 31 | 82,644 | 295,572 | ||||||
Non-IFRS Financial Measures – Reconciliation
Three months ended December 31, | Twelve months ended December 31, | |||||||||||||||
(Unaudited) | 2022 | 2021 | 2022 | 2021 | ||||||||||||
(in thousands $) | ||||||||||||||||
Loss for the period attributable to shareholders of the parent | (125,169 | ) | (79,753 | ) | (392,567 | ) | (212,393 | ) | ||||||||
Income tax (benefit)/expense | 3,236 | (5,434 | ) | (4,827 | ) | (2,655 | ) | |||||||||
Finance (income) and expenses, net | (3,098 | ) | (7,480 | ) | 1,409 | 1,305 | ||||||||||
Depreciation and amortization expense | 13,835 | 10,836 | 48,600 | 27,222 | ||||||||||||
EBITDA | (111,196 | ) | (81,831 | ) | (347,385 | ) | (186,521 | ) | ||||||||
Share-based compensation expense | 7,741 | 9,598 | 35,466 | 23,632 | ||||||||||||
Restructuring costs(1) | 3,410 | — | 4,415 | — | ||||||||||||
Product recall expenses(2) | — | 1,654 | — | 1,654 | ||||||||||||
Asset impairment and other costs related to assets held for sale(3) | 39,581 | 4,970 | 39,581 | 4,970 | ||||||||||||
IPO preparation and transaction costs | — | — | — | 9,288 | ||||||||||||
Adjusted EBITDA | (60,464 | ) | (65,609 | ) | (267,923 | ) | (146,977 | ) |
_________________
(1) Relates to accrued severance payments as the Company reviews its organizational structure to adjust the fixed cost base globally.
(2) Relates to the recall of products in Sweden as communicated on November 17, 2021. See the Company’s Form 6-K filed on November 17, 2021.
(3) The 2022 asset impairment charge relates to the YYF transaction. See the Company’s Form 6-K filed on January 3, 2023 and March 2, 2023 for details on the YYF transaction. The 2021 asset impairment charge related to production equipment at our Landskrona production facility in Sweden for which we had no alternative use.
FAQ
What were Oatly's revenue results for Q4 2022?
What is Oatly's revenue outlook for 2023?
What were Oatly's total revenue and net loss for 2022?
How much financing did Oatly secure recently?